CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.

CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.

Pulmonary delivery of plasmid DNA (pDNA)/cationic liposome complexes is associated with an acute unmethylated CG dinucleotide (CpG)-mediated inflammatory response and brief duration of transgene expression. We demonstrate that retention of even a single CpG in pDNA is sufficient to elicit an inflamm...

Cur síos iomlán

Sonraí bibleagrafaíochta
Príomhchruthaitheoirí:	Hyde, S, Pringle, I, Abdullah, S, Lawton, A, Davies, L, Varathalingam, A, Nunez-Alonso, G, Green, A, Bazzani, R, Sumner-Jones, S, Chan, M, Li, H, Yew, N, Cheng, S, Boyd, A, Davies, J, Griesenbach, U, Porteous, D, Sheppard, D, Munkonge, F, Alton, E, Gill, D
Formáid:	Journal article
Teanga:	English
Foilsithe / Cruthaithe:	2008

Míreanna comhchosúla

CpG-free plasmids confer reduced inflammation and sustained pulmonary gene expression.
de réir: Hyde, Stephen C., et al.
Foilsithe / Cruthaithe: (2008)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy
de réir: Pringle, I, et al.
Foilsithe / Cruthaithe: (2012)

CpG-free plasmid expression cassettes for cystic fibrosis gene therapy.
de réir: Pringle, I, et al.
Foilsithe / Cruthaithe: (2012)

Influence of CpG-dinucleotide motifs on the duration of gene expression from plasmid, vectors after in vivo lung delivery
de réir: Gill, DR, et al.
Foilsithe / Cruthaithe: (2007)

The use of CpG-free plasmids to mediate persistent gene expression following repeated aerosol delivery of pDNA/PEI complexes.
de réir: Davies, L, et al.
Foilsithe / Cruthaithe: (2012)

DEVELOPMENT, PRODUCTION AND EVALUATION OF CLINICAL GRADE CFTR EXPRESSION PLASMID FOR CF LUNG GENE THERAPY
de réir: Gill, DR, et al.
Foilsithe / Cruthaithe: (2010)

Adenovirus-mediated in utero expression of CFTR does not improve survival of CFTR knockout mice.
de réir: Davies, L, et al.
Foilsithe / Cruthaithe: (2008)

Electroporation enhances reporter gene expression following delivery of naked plasmid DNA to the lung.
de réir: Pringle, I, et al.
Foilsithe / Cruthaithe: (2007)

Assessment of CFTR function after gene transfer in vitro and in vivo.
de réir: Griesenbach, U, et al.
Foilsithe / Cruthaithe: (2008)

Transgene sequences free of CG dinucleotides lead to high level, long-term expression in the lung independent of plasmid backbone design
de réir: Bazzani, R, et al.
Foilsithe / Cruthaithe: (2016)

CpG-free plasmids for enhanced duration and reduced toxicity of non-viral airway gene transfer
de réir: Hyde, S
Foilsithe / Cruthaithe: (2008)

Long-term persistence of gene expression from adeno-associated virus serotype 5 in the mouse airways.
de réir: Sumner-Jones, S, et al.
Foilsithe / Cruthaithe: (2006)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CYSTIC FIBROSIS: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY''
de réir: Davies, J, et al.
Foilsithe / Cruthaithe: (2009)

REPEAT ADMINISTRATION OF GL67A/PGM169 IS FEASIBLE, SAFE, AND PRODUCES ENDOGENOUS LEVELS OF CFTR EXPRESSION AFTER 12 DOSES
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2012)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung.
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2014)

Toxicology study assessing efficacy and safety of repeated administration of lipid/DNA complexes to mouse lung
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2014)

Production of SIV-F/HN: a new Lentivirus vector for CF gene therapy
de réir: Hyde, S, et al.
Foilsithe / Cruthaithe: (2015)

Identification and functional characterization of cytoplasmic determinants of plasmid DNA nuclear import.
de réir: Munkonge, F, et al.
Foilsithe / Cruthaithe: (2009)

Cumulative CFTR expression following repeated aerosol delivery of non-viral pGM169/GL67A formulation to mouse lung
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2012)

743. Minicircles are similar to plasmids in providing high level, long-term expression in the lung
de réir: Gill, D, et al.
Foilsithe / Cruthaithe: (2016)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS: THE RUN-IN STUDY
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2010)

EVALUATION OF SAFETY AND GENE EXPRESSION WITH A SINGLE DOSE OF PGM169/GL67A ADMINISTERED TO THE NOSE AND LUNG OF INDIVIDUALS WITH CF: THE UK CF GENE THERAPY CONSORTIUM "PILOT STUDY"
de réir: Davies, J, et al.
Foilsithe / Cruthaithe: (2009)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CF
de réir: Davies, J, et al.
Foilsithe / Cruthaithe: (2011)

Topical delivery of NF-kb decoy related oligodeoxynucleotides reduces pro-inflammatory cytokine response associated with cationic lipid: pDNA vector delivery to murine lungs
de réir: Varathalingam, et al.
Foilsithe / Cruthaithe: (2004)

SAFETY AND EXPRESSION OF A SINGLE DOSE OF LIPID-MEDIATED CFTR GENE THERAPY TO THE UPPER AND LOWER AIRWAYS OF PATIENTS WITH CYSTIC FIBROSIS
de réir: Davies, G, et al.
Foilsithe / Cruthaithe: (2011)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2013)

A randomised, double-blind, placebo-controlled phase IIB clinical trial of repeated application of gene therapy in patients with cystic fibrosis.
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2013)

Transfection efficiency and toxicity following delivery of naked plasmid DNA and cationic lipid-DNA complexes to ovine lung segments.
de réir: Emerson, M, et al.
Foilsithe / Cruthaithe: (2003)

The effects of O6-methyl guanine DNA-methyl transferase promotor methylation and CpG1, CpG2, CpG3 and CpG4 methylation on treatment response and their prognostic significance in patients with glioblastoma
de réir: Yildiz OG, et al.
Foilsithe / Cruthaithe: (2020-08-01)

LONGITUDINAL ASSESSMENT OF BIOMARKERS FOR CLINICAL TRIALS OF NOVEL THERAPEUTIC AGENTS; THE RUN-IN STUDY
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2010)

A PHASE 2B DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL OF NON-VIRAL MEDIATED GENE THERAPY FOR CF
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2013)

Plasmid Inhalation: Delivery to the Airways
de réir: Davies, L, et al.
Foilsithe / Cruthaithe: (2006)

Efficient in vivo transfection and safety profile of a CpG-free and codon optimized luciferase plasmid using a cationic lipophosphoramidate in a multiple intravenous administration procedure
de réir: Lindberg, MF, et al.
Foilsithe / Cruthaithe: (2015)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2012)

UPDATE ON THE UK CF GENE THERAPY CONSORTIUM MULTIDOSE, NON-VIRAL, GENE THERAPY TRIAL
de réir: Alton, E, et al.
Foilsithe / Cruthaithe: (2012)

Progress and prospects: the design and production of plasmid vectors.
de réir: Gill, DR, et al.
Foilsithe / Cruthaithe: (2009)

Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment
de réir: Habib, Omar, et al.
Foilsithe / Cruthaithe: (2020)

Limited expression of non-integrating CpG-free plasmid is associated with increased nucleosome enrichment.
de réir: Omar Habib, et al.
Foilsithe / Cruthaithe: (2020-01-01)

In vivo control of CpG and non-CpG DNA methylation by DNA methyltransferases.
de réir: Julia Arand, et al.
Foilsithe / Cruthaithe: (2012-06-01)

CpG methylation of a plasmid vector results in extended transgene product expression by circumventing induction of immune responses.
de réir: Reyes-Sandoval, A, et al.
Foilsithe / Cruthaithe: (2004)